Amgen Inc (AMGN)
Pretax margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 7,855,000 | 8,751,000 | 9,196,000 | 9,113,000 | 7,346,000 | 7,729,000 | 7,492,000 | 6,519,000 | 6,701,000 | 6,447,000 | 6,498,000 | 7,970,000 | 8,133,000 | 8,239,000 | 8,310,000 | 8,844,000 | 9,138,000 | 9,340,000 | 9,157,000 | 9,240,000 |
| Revenue (ttm) | US$ in thousands | 25,976,000 | 18,426,000 | 18,462,000 | 18,381,000 | 18,649,000 | 51,099,000 | 51,147,000 | 51,407,000 | 51,365,000 | 25,471,000 | 25,484,000 | 25,164,000 | 25,424,000 | 24,987,000 | 24,301,000 | 23,966,000 | 23,362,000 | 23,395,000 | 23,562,000 | 23,750,000 |
| Pretax margin | 30.24% | 47.49% | 49.81% | 49.58% | 39.39% | 15.13% | 14.65% | 12.68% | 13.05% | 25.31% | 25.50% | 31.67% | 31.99% | 32.97% | 34.20% | 36.90% | 39.11% | 39.92% | 38.86% | 38.91% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $7,855,000K ÷ $25,976,000K
= 30.24%
To analyze AMGEN Inc.'s pretax margin, we observe a fluctuating trend over the past eight quarters. In the most recent quarter of Q4 2023, the pretax margin stood at 27.86%, which was lower compared to the previous two quarters where it was 32.61% in Q3 2023 and 34.59% in Q2 2023.
However, the pretax margin in Q4 2023 still showed improvement from the same period in the previous year, Q4 2022, where it was 27.91%. This suggests a positive year-over-year comparison.
The highest pretax margin in the provided data is seen in Q2 2023 at 34.80%, indicating strong profitability before a slight decline in the following quarters.
On average, the pretax margin over the past eight quarters appears to be relatively healthy, with Q2 and Q3 of both 2023 and 2022 reflecting the strongest performance. It is essential for investors and stakeholders to monitor these trends to gauge the company's operational efficiency and profitability levels.
Peer comparison
Dec 31, 2023